IBDEI0BA ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15095,1,5,0)
 ;;=5^Chr Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,15095,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,15096,0)
 ;;=453.89^^85^888^1
 ;;^UTILITY(U,$J,358.3,15096,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15096,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,15096,1,5,0)
 ;;=5^AC Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,15096,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,15097,0)
 ;;=454.2^^85^888^85
 ;;^UTILITY(U,$J,358.3,15097,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15097,1,4,0)
 ;;=4^454.2
 ;;^UTILITY(U,$J,358.3,15097,1,5,0)
 ;;=5^Varicose Veins w/Ulcer&Inflam
 ;;^UTILITY(U,$J,358.3,15097,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,15098,0)
 ;;=397.1^^85^888^74
 ;;^UTILITY(U,$J,358.3,15098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15098,1,4,0)
 ;;=4^397.1
 ;;^UTILITY(U,$J,358.3,15098,1,5,0)
 ;;=5^Rheumatic Disease Pulmonary Valve
 ;;^UTILITY(U,$J,358.3,15098,2)
 ;;=^269587
 ;;^UTILITY(U,$J,358.3,15099,0)
 ;;=397.0^^85^888^75
 ;;^UTILITY(U,$J,358.3,15099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15099,1,4,0)
 ;;=4^397.0
 ;;^UTILITY(U,$J,358.3,15099,1,5,0)
 ;;=5^Rheumatic Disease Tricuspid Valve
 ;;^UTILITY(U,$J,358.3,15099,2)
 ;;=^35528
 ;;^UTILITY(U,$J,358.3,15100,0)
 ;;=414.3^^85^888^17
 ;;^UTILITY(U,$J,358.3,15100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15100,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,15100,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,15100,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,15101,0)
 ;;=414.4^^85^888^16
 ;;^UTILITY(U,$J,358.3,15101,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15101,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,15101,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,15101,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,15102,0)
 ;;=425.11^^85^888^60
 ;;^UTILITY(U,$J,358.3,15102,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15102,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,15102,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,15102,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,15103,0)
 ;;=425.18^^85^888^59
 ;;^UTILITY(U,$J,358.3,15103,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15103,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,15103,1,5,0)
 ;;=5^Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,15103,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,15104,0)
 ;;=V12.55^^85^888^54
 ;;^UTILITY(U,$J,358.3,15104,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15104,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,15104,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,15104,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,15105,0)
 ;;=454.9^^85^888^84
 ;;^UTILITY(U,$J,358.3,15105,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15105,1,4,0)
 ;;=4^454.9
 ;;^UTILITY(U,$J,358.3,15105,1,5,0)
 ;;=5^Varicose Veins
 ;;^UTILITY(U,$J,358.3,15105,2)
 ;;=^328758
 ;;^UTILITY(U,$J,358.3,15106,0)
 ;;=271.3^^85^889^11
 ;;^UTILITY(U,$J,358.3,15106,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15106,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,15106,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,15106,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,15107,0)
 ;;=611.1^^85^889^16
 ;;^UTILITY(U,$J,358.3,15107,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15107,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,15107,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,15107,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,15108,0)
 ;;=704.1^^85^889^17
 ;;^UTILITY(U,$J,358.3,15108,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15108,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,15108,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,15108,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,15109,0)
 ;;=251.2^^85^889^30
 ;;^UTILITY(U,$J,358.3,15109,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15109,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,15109,1,5,0)
 ;;=5^Hypoglycemia NOS
 ;;^UTILITY(U,$J,358.3,15109,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,15110,0)
 ;;=253.2^^85^889^34
 ;;^UTILITY(U,$J,358.3,15110,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15110,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,15110,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,15110,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,15111,0)
 ;;=733.00^^85^889^43
 ;;^UTILITY(U,$J,358.3,15111,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15111,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,15111,1,5,0)
 ;;=5^Osteoporosis NOS
 ;;^UTILITY(U,$J,358.3,15111,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,15112,0)
 ;;=278.00^^85^889^40
 ;;^UTILITY(U,$J,358.3,15112,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15112,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,15112,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,15112,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,15113,0)
 ;;=278.01^^85^889^39
 ;;^UTILITY(U,$J,358.3,15113,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15113,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,15113,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,15113,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,15114,0)
 ;;=250.80^^85^889^10
 ;;^UTILITY(U,$J,358.3,15114,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15114,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,15114,1,5,0)
 ;;=5^DM Type II with LE Ulcer
 ;;^UTILITY(U,$J,358.3,15114,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,15115,0)
 ;;=250.00^^85^889^5
 ;;^UTILITY(U,$J,358.3,15115,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15115,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,15115,1,5,0)
 ;;=5^DM Type II Dm W/O Complications
 ;;^UTILITY(U,$J,358.3,15115,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,15116,0)
 ;;=250.40^^85^889^6
 ;;^UTILITY(U,$J,358.3,15116,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15116,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,15116,1,5,0)
 ;;=5^DM Type II Dm with Nephropathy
 ;;^UTILITY(U,$J,358.3,15116,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,15117,0)
 ;;=250.50^^85^889^9
 ;;^UTILITY(U,$J,358.3,15117,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15117,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,15117,1,5,0)
 ;;=5^DM Type II w/ PDR
 ;;^UTILITY(U,$J,358.3,15117,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,15118,0)
 ;;=250.60^^85^889^7
 ;;^UTILITY(U,$J,358.3,15118,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15118,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,15118,1,5,0)
 ;;=5^DM Type II Dm with Neuropathy
 ;;^UTILITY(U,$J,358.3,15118,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,15119,0)
 ;;=250.70^^85^889^8
 ;;^UTILITY(U,$J,358.3,15119,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15119,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,15119,1,5,0)
 ;;=5^DM Type II Dm with Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,15119,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,15120,0)
 ;;=250.01^^85^889^4
 ;;^UTILITY(U,$J,358.3,15120,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15120,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,15120,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,15120,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,15121,0)
 ;;=272.0^^85^889^22
 ;;^UTILITY(U,$J,358.3,15121,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15121,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,15121,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,15121,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,15122,0)
 ;;=272.1^^85^889^28
 ;;^UTILITY(U,$J,358.3,15122,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15122,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,15122,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,15122,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,15123,0)
 ;;=272.2^^85^889^24
 ;;^UTILITY(U,$J,358.3,15123,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15123,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,15123,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,15123,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,15124,0)
 ;;=275.42^^85^889^21
 ;;^UTILITY(U,$J,358.3,15124,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15124,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,15124,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,15124,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,15125,0)
 ;;=275.41^^85^889^29
 ;;^UTILITY(U,$J,358.3,15125,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15125,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,15125,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,15125,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,15126,0)
 ;;=276.7^^85^889^23
 ;;^UTILITY(U,$J,358.3,15126,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15126,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,15126,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,15126,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,15127,0)
 ;;=275.2^^85^889^19
 ;;^UTILITY(U,$J,358.3,15127,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15127,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,15127,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,15127,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,15128,0)
 ;;=276.0^^85^889^25
 ;;^UTILITY(U,$J,358.3,15128,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15128,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,15128,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,15128,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,15129,0)
 ;;=276.1^^85^889^32
 ;;^UTILITY(U,$J,358.3,15129,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15129,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,15129,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,15129,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,15130,0)
 ;;=275.3^^85^889^20
 ;;^UTILITY(U,$J,358.3,15130,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15130,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,15130,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,15130,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,15131,0)
 ;;=240.0^^85^889^14
 ;;^UTILITY(U,$J,358.3,15131,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15131,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,15131,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,15131,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,15132,0)
 ;;=241.1^^85^889^13
 ;;^UTILITY(U,$J,358.3,15132,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15132,1,4,0)
 ;;=4^241.1
